Top Industry Leaders in the Multiplex Assays Market
Latest Multiplex Assays Companies Updates:
Luminex Corporation acquired by DiaSorin S.p.A. in a USD 1.8 billion deal: This consolidation strengthens DiaSorin's position in the multiplex assay market, particularly in molecular diagnostics.
Becton, Dickinson and Company (BD) launched its BD COR System: This fully automated system leverages robotics and software to set a new standard in workflow efficiency for infectious disease molecular testing.
InDevR, Inc. launched a VaxArray Pneumococcal Assay kits: This rapid and accurate multiplex assay assesses pneumococcal vaccines at various stages of manufacturing.
Vela Diagnostics launched PathoKey MP UTI ID and AMR PCR Test: This research-use tool offers simultaneous identification and antibiotic susceptibility testing for urinary tract infections.Sentinel Diagnostics launched SentiNat 200 and Stat-Nat SN200 Real-Time PCR assays: This fully automated system and assays enable quantitative detection of 10 viruses common in respiratory infections.
List of Multiplex Assays companies in the market:
- Thermo Fisher Scientific Inc
- Illumina Inc
- Bio-Rad Laboratories Inc
- Qiagen
- Abcam plc
- BD
- Merck Sharp & Dohme Corp
- Agilent Technologies
- Meso Scale Diagnostics LLC
- Randox Laboratories Ltd
